您所在的位置:
作者:Shannon O'Connor
单位:Université de Montréal

摘要

Introduction: Periodontal disease (PD) is associated with increased risk of Alzheimer’s disease (AD), and the keystone periodontal pathogen Porphyromonas gingivalis (PG) has been implicated in this relationship. However, the mechanisms through which PG influences the central nervous system remain incompletely understood, particularly whether it directly translocates across the blood-brain barrier (BBB) or interacts with the cerebral vasculature to influence the perivascular environment and neuroinflammatory processes. SCPPPQ1, a naturally occurring protein produced by dento-gingival junction tissue, exhibits antimicrobial activity against PG and may provide a means of targeting periodontal infection at its source.


Methods: Two PG strains (W83 and ATCC 33277) were fluorescently labelled and administered intravenously (109 CFU in saline) to wild-type mice and rats. Animals were sacrificed after one hour. Bacterial distribution and localization in the cerebral vasculature and peripheral organs were investigated using fluorescence imaging, two-photon microscopy, and scanning electron microscopy (SEM). Ongoing studies will employ chronic PD models to investigate whether SCPPPQ1 treatment attenuates neurodegenerative changes and AD-relevant neuropathology, using in vivo neuroimaging techniques and array tomography approaches.


Results: Following intravenous administration, initial findings across four animals demonstrated the presence of PG in the cerebral vasculature and peripheral organs, including the liver and lungs. Two-photon microscopy and fluorescence imaging revealed focal bacterial accumulation, including large aggregates associated with cerebral vessels. SEM additionally identified PG within cerebral vessels and PG engulfed by peripheral immune cells in the liver and lung across animals. Further investigations are underway to determine whether PG can translocate beyond the BBB.


Conclusions: This investigation aims to elucidate how circulating PG interacts with the cerebral vasculature and perivascular environment, and how these interactions may contribute to AD-related pathology. Ongoing studies will evaluate whether targeting periodontal PG with SCPPPQ1 can mitigate neurovascular dysfunction and downstream neuropathological changes, potentially identifying a therapeutic strategy to reduce PD-associated contributions to AD progression.



相关会议

更多
“医”路携手,“药”有作为一基层抗感染系列学术研讨会(3)
2026-11-30
北京
重庆市医师协会器官移植医师分会2026年学术年会
2026-11-30
待定

相关直播

更多
第八届上海国际癌症大会
2026-06-03
上海静安英迪格酒店
观看回放
产前咨询
2026-09-01
产前咨询
观看回放
冠心病及腔内影像生理学规范诊疗系列课程:左心室血栓的诊疗新进展
2026-11-17
阜外医院冠心病一病区
观看回放

最新视频

更多
糖尿病分型诊断中国专家共识解读
徐静
西安交通大学第二附属医院
李宗恩授课
李宗恩
病例分享
王攀霞
喀什市人民医院
高脂血症与急性胰腺炎
高静
新疆医科大学第五附属医院